4
Changes in Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-17-000062
Chief Development Officer acquired 215,453 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bachinski Thomas · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-07-20 | Grant or award : show line 1 in the form | +215,453 | 215,453 | D |
Loading xslF345X03/primary_doc.xml…